Hematopoietic stem cell transplant (HSCT), allogeneic, graft-versus-host disease

Do Not Use

For the following indications, there is insufficient or no evidence to support the use of IG. Alternatives to IG are often available.

Recommendations

IG is not recommended for the specific prevention or treatment of graft-versus-host disease in allogeneic HSCT.

(see separate entry for secondary hypogammaglobulinemia)